Jefferies Downgrades Apellis Pharmaceuticals (APLS) to Hold

March 31, 2026 1:12 PM

Jefferies analyst Akash Tewari downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found